IP
CLB icon

Isthmus Partners’s Core Laboratories CLB Stock Holding History

Isthmus Partners’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$243K Buy
20,823
+6,314
+44% +$90.1K 0.02% 209
2026
Q1 		$244K Buy
14,509
+2,027
+16% +$36.3K 0.03% 205
2025
Q4 		$200K Buy
12,482
+334
+3% +$4.97K 0.02% 212
2025
Q3 		$150 Buy
12,148
+256
+2% +$3K ﹤0.01% 175
2025
Q2 		$137K Buy
11,892
+424
+4% +$5.03K 0.02% 216
2025
Q1 		$172K Buy
11,468
+249
+2% +$4.17K 0.02% 210
2024
Q4 		$194K Buy
11,219
+599
+6% +$11.6K 0.02% 215
2024
Q3 		$197K Buy
+10,620
New +$213K 0.02% 194

Other funds holding CLB

CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
ECM
Evergreen Capital Management Bellevue, Washington $5.7B AUM 32.06% 1-Year Est. Return
BP
BWM Planning The Woodlands, Texas $431M AUM 26% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
TB
Terril Brothers St. Louis, Missouri $388M AUM 29.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

Isthmus Partners's CLB Position: Q2 2026 in Review

Isthmus Partners increased its Core Laboratories (CLB) stake by 44% in Q2 2026, buying an estimated $90.1K and bringing the position to 20,823 shares worth $243K. The position accounts for 0.02% of the portfolio, ranked #209.

Isthmus Partners first reported a position in CLB in Q3 2024 and has held it in 8 quarters since. The position peaked at $244K in Q1 2026. 30 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Isthmus Partners held 20,823 shares of Core Laboratories worth $243K as of Q2 2026.
  • Isthmus Partners bought 6,314 Core Laboratories shares in Q2 2026, an estimated $90.1K.
  • Core Laboratories made up 0.02% of Isthmus Partners's portfolio in Q2 2026, its #209 holding.
  • Isthmus Partners first reported a position in Core Laboratories in Q3 2024 and has held it in 8 quarters since.
  • Isthmus Partners's Core Laboratories position peaked at $244K in Q1 2026.
  • 30 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Isthmus Partners's 13F filing for Q2 2026, filed 20 Jul 2026.